Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Anavex Lf SC (NQ: AVXL )

7.240 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 20, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 7.240
Bid (Size) 6.800 (20)
Ask (Size) 8.000 (21)
Prev. Close 7.240
Today's Range 7.240 - 7.240
52wk Range 6.810 - 15.24
Shares Outstanding 81,951,115
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Cutera Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Wednesday's Session
Gainers Tango Therapeutics, Inc. (NASDAQ: TNGX) climbed 85.2% to $7.09 after gaining 11% on Tuesday. Tango Therapeutics recently posted a narrower quarterly loss. 
Via Benzinga
Preview: Anavex Life Sciences's Earnings
Via Benzinga

Performance

YTD
-25.21%
-25.21%
1 Month
-11.38%
-11.38%
3 Month
-15.02%
-15.02%
6 Month
-15.02%
-15.02%
1 Year
-21.30%
-21.30%

More News

Read More
The Latest Analyst Ratings for Anavex Life Sciences
Via Benzinga
Analyst Ratings for Anavex Life Sciences
Via Benzinga
This Short-Squeeze Candidate Could Actually Pan Out in the Long Run
Via The Motley Fool
Akamai Technologies, Array Technologies Music, HNI, PENN Entertainment And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Topics Stocks
Exposures US Equities
Anavex Life Sciences Releases Encouraging Long Term Data From Rett Syndrome Study
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
What's Going On With Anavex Life Sciences Shares Today?
Via Benzinga
Earnings Preview: Anavex Life Sciences
Via Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $3,000 Today
Via Benzinga
Here's How Much $100 Invested In Anavex Life Sciences 5 Years Ago Would Be Worth Today
Via Benzinga
Here's How Much You Would Have Made Owning Anavex Life Sciences Stock In The Last 5 Years
Via Benzinga
Wall Street Thinks This Small-Cap Stock Can Quadruple in Value
Via The Motley Fool
Why Shares of Anavex Life Sciences Rose 12.4% in February
Via The Motley Fool
Is Anavex Life Sciences Stock a Buy Now?
Via The Motley Fool
Why Anavex Life Sciences Stock Bolted Higher in January
Via The Motley Fool
Anavex Life Sciences Stock Shows Improved Price Strength Rating
Via Investor's Business Daily
3 Biotech Stocks Under $15 Worth a Second Look in 2023
Via The Motley Fool
Top Picks For 2023: Anavex Life Sciences
Via Talk Markets
Tesla To $205? Here Are 10 Other Price Target Changes For Tuesday
Via Benzinga
Analyzing Anavex Life Sciences's Short Interest
Via Benzinga
Anavex Life Sciences Stock Could 5x Before 2025 -- Here's Why
Via The Motley Fool
Is Anavex Life Sciences a Buy?
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.